Literature DB >> 1379101

Laser ablation of the prostate in patients with benign prostatic hypertrophy.

A J Costello1, W G Bowsher, D M Bolton, K G Braslis, J Burt.   

Abstract

Seventeen patients with bladder neck obstruction due to benign prostatic hypertrophy have been treated with the Neodymium: YAG laser. We review our experience since the first patient was treated in September 1990. Using a prototype deflecting gold alloy tip on a quartz laser fibre (Lateralase TM), we ablated obstructing prostatic adenoma and constricting bladder neck tissue. Experience with this technique has enabled a patient population to be defined in whom laser therapy for prostatic obstruction may be effective. The treatment is relatively simple, speedy and attended by virtually no blood loss. Laser ablation therapy may offer some advantages over conventional transurethral resection of the prostate (TURP) in a selected subgroup of patients. The advent of new delivery systems may make laser ablation therapy a practical alternative to TURP.

Entities:  

Mesh:

Year:  1992        PMID: 1379101     DOI: 10.1111/j.1464-410x.1992.tb15631.x

Source DB:  PubMed          Journal:  Br J Urol        ISSN: 0007-1331


  38 in total

1.  Enhancement of tissue lesion depth by dual wavelength irradiation with the Nd-YAG/KTP laser: Perspectives for laser prostatectomy.

Authors:  F Schmidlin; G Delacrètaz; M Oswald; C Iselin; P Jichlinski; B Mermillod; R Lemoine; H J Leisinger; P Graber
Journal:  Lasers Med Sci       Date:  1997-12       Impact factor: 3.161

2.  Prostate vaporization in the treatment of benign prostatic hyperplasia by using a 200-w high-intensity diode laser.

Authors:  Po-Hui Chiang; Chien-Hsu Chen
Journal:  Curr Urol Rep       Date:  2010-07       Impact factor: 3.092

3.  A feasibility study on monitoring the evolution of apparent diffusion coefficient decrease during thermal ablation.

Authors:  Juan C Plata; Andrew B Holbrook; Michael Marx; Vasant Salgaonkar; Peter Jones; Aurea Pascal-Tenorio; Donna Bouley; Chris Diederich; Graham Sommer; Kim Butts Pauly
Journal:  Med Phys       Date:  2015-09       Impact factor: 4.071

4.  Economic impact of surgical intervention in the treatment of benign prostatic hyperplasia.

Authors:  John M Hollingsworth; John T Wei
Journal:  Rev Urol       Date:  2006

5.  [Diode laser. Ex vivo studies on vaporization and coagulation characteristics].

Authors:  M Seitz; A Ackermann; C Gratzke; B Schlenker; R Ruszat; A Bachmann; C Stief; O Reich; R Sroka
Journal:  Urologe A       Date:  2007-09       Impact factor: 0.639

6.  Ex vivo and in vivo investigations of the novel 1,470 nm diode laser for potential treatment of benign prostatic enlargement.

Authors:  Michael Seitz; Robin Ruszat; Thomas Bayer; Derya Tilki; Alexander Bachmann; Christian Stief; Ronald Sroka; Oliver Reich
Journal:  Lasers Med Sci       Date:  2008-08-07       Impact factor: 3.161

7.  New alternatives for laser vaporization of the prostate: experimental evaluation of a 980-, 1,318- and 1,470-nm diode laser device.

Authors:  Felix Wezel; Gunnar Wendt-Nordahl; Nina Huck; Thorsten Bach; Christel Weiss; Maurice Stephan Michel; Axel Häcker
Journal:  World J Urol       Date:  2009-12-25       Impact factor: 4.226

8.  Management of benign prostatic hyperplasia.

Authors:  S D Boyd; P Narayan
Journal:  West J Med       Date:  1994-02

9.  Laser prostatectomy for patients with benign prostatic hyperplasia: a prospective randomized study comparing two different techniques using the Prolase-II fiber.

Authors:  T A Boon; C F van Swol; G E van Venrooij; H P Beerlage; R M Verdaasdonk
Journal:  World J Urol       Date:  1995       Impact factor: 4.226

10.  [Thulium:YAG vaporesection of the prostate. First results].

Authors:  T Bach; T R W Herrmann; R Ganzer; A Blana; M Burchardt; A J Gross
Journal:  Urologe A       Date:  2009-05       Impact factor: 0.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.